GENE ONLINE|News &
Opinion
Blog

Chugai Pharmaceutical
Japan’s Red Biotechnology and International Business Partnering Take Spotlight on BioJapan 2023
2023-11-03
Building Bridges at the Brand-New Chugai Life Science Park
2023-10-10
Japan’s Chugai Infuses $500 Million for a New API Manufacturing Building
2021-07-29
Chugai Initiates Actemra’s Phase 3 COVID-19 Trials in Japan
2020-04-11
FDA
Weekly Cover:Foundation Medicine and Chugai Partnership with National Cancer Center
2020-02-18
Weekly Cover: Expansion of Samsung Biologics Projects into U.S. and Europe
2020-02-11
Weekly Cover: Acepodia’s NK Cell Therapy Drug Candidate ACE1702 Receives FDA Clearance of IND
2020-01-15
Weekly in Asia|Nov-3
2019-12-03
Weekly in Asia|Nov
2019-11-07
Weekly in Asia(0407-0413)
2019-04-19
Roche Announces Analysis of Hemlibra’s Phase III HAVEN 2 Study at ASH meeting
2018-12-21
Emicizumab promises weekly/biweekly prophylaxis in hemophilia-A patients
2018-09-04
LATEST
Breakthrough Stem Cell Treatment Shows Promise in Reversing Liver Disease
2023-12-08
2023 Taiwan Healthcare Expo: Showcasing Innovative Advances in Biomedical Technology
2023-12-07
Absci Accelerates Breakthroughs in AI-Designed Drugs with AstraZeneca and Almirall Collaborations
2023-12-06
Saving Lives Through Communication, Heroic Faith Medical Science Showcasing Novel AI Auscultation Tool for Procedural Sedation Patients in PGA 77
2023-12-05
AbbVie Invests $10.1 Billion in ImmunoGen, Targeting the Ovarian Cancer Landscape
2023-12-05
PRISM BioLab and Eli Lilly Join Forces in Revolutionary Drug Discovery Collaboration
2023-12-05
Novel Hydrogel Delivery System Could Reduce Daily Diabetes Injections to Three Times a Year
2023-12-04
EVENT
Scroll to Top